Please, Not Another “Blue Ribbon” Committee
Austin Frakt in a February 12, 2021 piece, posted both in Upshot and the Incidental Economist , argues that the Biden administration should establish a committee to determine appropriate prices for pharmaceuticals. This commentary contests both his economic and political arguments. Frakt’s argument seems to be based on the following claims: There exists a … More Please, Not Another “Blue Ribbon” Committee